Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02375841 · ClinicalTrials.gov registry record
Coping With Glioblastoma: A Study of Communication Between Physicians, Patients, and Caregivers
A clinical trial of Glioblastoma and Brain Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- 309
- Enrollment target
- 8
- Study locations
NCT02375841: Active study of Glioblastoma and Brain Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02375841 is a study of Glioblastoma and Brain Cancer that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 309 participants, above the 107-participant average among 199 other Glioblastoma trials with a reported enrollment target (189% higher). The trial reports 8 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02375841, a study of Glioblastoma and Brain Cancer, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 309 participants
- Enrollment target
- 8
- Study locations
Study Summary
The purpose of this study is to learn more about the way physicians communicate with brain tumor patients. This study will look at how oncologists provide information about brain tumors, brain scan results, and treatment options. This study will look at how oncologists provide information about brain tumors, brain scan results, and treatment options. Ultimately, the investigators hope to use these findings to improve communication between patients, caregivers and their doctors.
Conditions Studied
Interventions
- BEHAVIORAL psychometric tests, questionnaires and neurocognitive assessments
Study Locations (8)
New Jersey
- Memorial Sloan Kettering Basking Ridge - Basking Ridge
- Memorial Sloan Kettering Monmouth - Middletown
- Memorial Sloan Kettering Bergen - Montvale
New York
- Memorial Sloan Kettering Commack - Commack
- Memorial Sloan Kettering Westchester - Harrison
- Memorial Sloan Kettering Cancer Center - New York
Michigan
- Henry Ford Hospital - Detroit
Vermont
- University of Vermont Medical Center - Burlington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 309 participants |
| Start Date | 2015-02 |
| Est. Completion | 2027-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02375841
The ClinicalTrials.gov registry entry for NCT02375841 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 309 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 107-participant average among 199 other Glioblastoma trials with a reported enrollment target (189% higher). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Glioblastoma appearing as the primary indexed condition, and to 1 intervention - of which psychometric tests, questionnaires and neurocognitive assessments is the first listed.
NCT02375841 reports 8 study locations spanning 4 distinct geographic areas - top geographies include New Jersey, New York, Michigan.
Frequently Asked Questions
What is clinical trial NCT02375841 about?
NCT02375841 is a clinical study titled "Coping With Glioblastoma: A Study of Communication Between Physicians, Patients, and Caregivers". The purpose of this study is to learn more about the way physicians communicate with brain tumor patients. This study will look at how oncologists provide information about brain tumors, brain scan results, and treatment options. This study will look at how oncologists provide information about brai...
What is the current status of trial NCT02375841?
This trial is currently active not recruiting. The enrollment target is 309 participants. The study started on 2015-02. Estimated completion is 2027-02.
What conditions does trial NCT02375841 study?
This clinical trial studies the following conditions: Glioblastoma, Brain Cancer.
What interventions are being tested in trial NCT02375841?
The interventions under investigation include: psychometric tests, questionnaires and neurocognitive assessments (BEHAVIORAL).
Who is sponsoring clinical trial NCT02375841?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02375841 being conducted?
This trial has 8 study locations across Michigan, New Jersey, New York, Vermont. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glioblastoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
NovoTTF Treatment Signatures in Glioblastoma Patients At Autopsy
RECRUITING
-
Glioblastoma Remote Monitoring and Care - Research Protocol
RECRUITING · NA
-
Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas
RECRUITING · Phase 2
-
Venous Thromboembolism Prevention in Outpatients With Glioma
RECRUITING · Phase 2
-
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
RECRUITING · Phase 1
-
A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma
RECRUITING · Phase 1
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.